Skip to main content

Table 2 Plant-based Silver Nanoparticles for antiviral activity

From: Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity

Method of synthesis of AgNPs

Type of virus

Characterization

Shape

Size

Viral model

Assays/ Evaluation parameters

MOA

Doses

References

Biological synthesis using fungi

Herpes Simplex Virus & Human Parainfluenza Virus Type 3

TEM, UV–Vis, zeta potential

Spherical

46 nm and 40 nm

VERO cells

MTT assay, cotreatment assay, cell pretreatment assay, cell post-treatment assay, Virus pretreatment assay

Inhibits viral replication

ID50-10 mg/mL,

[115]

Biological synthesis using seaweeds

HSV-1 and HSV-2

UV–Vis, FTIR, XRD, TEM,

Spherical

8-27 nm

Vero cells

Cytotoxic assay, antiviral assay

Cytotoxic

ID50-2.5 μL

[124, 125]

Biological synthesis using Bacteria (Bacillus species)

Bean Yellow Mosaic Virus

UV–VIS, EDX, TEM, DLS, FTIR

Triangular, Hexagonal and Spherical

77–92 nm

Seeds of Vicia faba

RT-PCR, ELIZA

Inhibit the growth of virus

[126]

Biological synthesis (Bio-reduction)

Bombyx mori Nuclear Polyhedrosis virus (BmNPV)

HR-SEM, EDAX, TEM, AFM CM

Hexahedron

0.87–1.2 µm

Silkworm (Bombyx mori)

SDS-PAGE analysis, Energy Dispersive X-ray Analysis

Interact with cell membrane of virus

[127]

Chemical synthesis (citrate-stabilized AgNPs)

Feline Calicivirus

SEM, Mass spectroscopy, DLS,

Spherical

10, 75, and 110 nm

FCV strain 2280 (ATCC-VR-2057) and Crandell-Rees feline kidney (CRFK) cells

Infectivity assay, Western blot analysis, Cytotoxic assay, SDS-PAGE analysis,

Cytotoxic, viricidal

25, 50, & 100 lg/ mL

[113]

Chemical synthesis (non-surface capped AgNPs)

Vaccinia virus

TEM, XRD

Spherical

25 nm ± 10 nm,

VERO 76, BS-C-1, HeLa

Plaque Assay, VACV Adsorption Plaque Assay, Beta-Galactosidase Assay, Viral Entry Assay, VACV Adsorption Confocal Assay, MTT Assay, Dextran Uptake Assay, Western Blot

Macropinocytosis, interferes the entry

27.4 ± 3.3 µg/ml

[128]

Chemical synthesis—Polyol method (PVP-coated AgNPs), carbon-coated AgNPs, bovine-serum AgNPs

HIV-1

TEM, STEM, UV–Vis, EDS,

Spherical

PVP-coated- 6.53 nm

Carbon-coated- 16.19 nm

Bovine-serum AgNPs- 2.08 nm

MT-2, cMAGI HIV-1 cells

Inhibition of HIV-1 with AgNPs analysis

Interact with the glycoprotein of virus,

25 µg/mL

[107]

Chemical synthesis using Tannic acid

Adeno virus type 3

TEM

Hexahedron

70-90 nm

HeLa cells

Cytotoxicity test, MTT assay, immunofluorescence analysis, RT-PCR

Interact with DNA,

9.3 µg/mL

[108]

Chemical synthesis using citrate, PVP, H2O2

bovine herpesvirus-1

TEM, UV–Vis, zeta-sizer,

Spherical

20–25 nm

MDBK cells

Cytotoxicity assay, colorimetric-based assay, Anti-BoHV-1 effect of Ag-NPs, cytopathic effects analysis,

Attach to glycoprotein and inhibit viral normal functioning

24 µg/mL

[114, 129]

Chemical synthesis (uncoated and polysaccharide coated AgNPs)

Tacaribe virus (TCRV)

TEM

Spherical

10 and 25 nm

Vero cells

Viral Inhibition Assay, S segment real time PCR, Post-infection treatment with Ag-NPs study

Inhibits early stage of viral replication

25 μg/ml

[117]

Chemical synthesis using chitosan as stabilizer

African swine fever virus (ASFV)

TEM, UV–Vis,

Spherical

14 nm

Primary porcine alveolar macrophages (PAMs)

Cell toxicity test, Antivirus activity

Strong antiviral activity

0.78 ppm

[130]

Chemical synthesis (coated PVP)

Respiratory syncytial virus (RSV)

SEM, TEM

Spherical

8–12 nm

A549 cells (a human alveolar type II-like epithelial cell lines) & HEp-2 Cell

qRT-PCR assays, Airway Obstruction analysis, ELISA, plaque assay

Interact with glycoproteins, prevent fusion

50 µg/mL

[131]

Chemical synthesis (curcumin modified AgNPs)

Respiratory Syncytial Virus Infection

DLS, XPS, UV/vis, TEM, SEM, FTIR, zeta-sizer,

Spherical

11.95 ± 0.23 nm

Hep-2 cells

Tissue culture infectious doses (TCID50) assay, Viral titer assay, Plaque assay, Indirect immunofluorescence assay, cytopathic effect analysis, RT-PCR analysis,

Inactivate virus, inhibits entry into host cell

 

[121]

Chemical synthesis (PVP coated)

Herpes simplex virus 2

SEM, TEM

Spherical

30–40 nm

Vero cells

MTT assay, Trypan blue assay, Viral suppression experiments, cytopathic effect analysis

Inhibits virus replication

6.25- 100 μg/mL

[109]

Chemical synthesis (PVP coated)

HIV-1

SEM, TEM

Spherical

30–50 nm

HeLa-CD4-LTR-b-gal cells

Virus adsorption assays, HIV-1 infectivity inhibition assays, Cell-based fusion assay, HIV-1 gp120/CD4 ELISA Time-of-addition experiments, Virucidal activity assay

Interact with gp120 protein, inhibits binding and fusion

0.44 mg/mL (± 0.3)

[116]

Chemical synthesis (PVP-coated)

White Spot Syndrome Virus (WSSV)

TEM, FTIR, Zeta potential, UV–Vis

Spherical

1-90 nm

Shrimp (P. vannamei)

Histologic analysis, qRT-PCR WSSV-diagnosis, WSSV challenge bioassay,

Interfere with the viral envelopes

0.5–20 mg/mL

[132]

Chemical synthesis method (chitosan coated AgNPs)

H1N1 influenza virus

TEM, SEM, UV–Vis

Spherical

MDCK cells (Madin-darby canine kidney cells)

Antiviral assay

Damage virus protein

100 µg/mL

[123]

Chemical synthesis using Graphene oxide

Feline Coronavirus (Fcov)

HR-TEM, FE-SEM, XRD, XPS, AFM, TGA,

Spherical

5 and 25 nm

Felis catus whole fetus-4 (fcwf-4) cells

Tissue culture infectious dose (TCID) assay, Virus Inhibition Assay

Interferes with the lipid membrane of corona virus and ruptures it

0.1 mg/mL

[105]

Chemical synthesis using Graphene oxide

Infectious Bursal Disease Virus (IBDV)

HR-TEM, FE-SEM, XRD, XPS, AFM, TGA,

Spherical

5 and 25 nm

DF-1 cells

Tissue culture infectious dose (TCID) assay, Virus Inhibition Assay

Interferes with the viral protein

0.125 mg/mL

[105]

Chemical synthesis (Magnetic hybrid colloids- AgNPs)

Bacteriophage-X174, Murine norovirus (MNV), Adeno virus serotype2(Adv2)

SEM, TEM, EDS, ESEM

Spherical

7, 15, and 30 nm

-

Plaque assay, Real-time TaqMan PCR (RT-PCR) assays

Interact with viral protein, damage viral coating

57.5-400 ppm

[122, 133]

Electrochemical method

Poliovirus

FE-SEM, TEM, UV–Vis, EDX

Spherical

4 to 9 nm

Human rhabdomyosarcoma (ATCC # CCL-136) cells

MTT assay antiviral evaluation

Inhibits the polio virus particles

3.13 ppm

[134]

Essential oil reduction method using Aquilaria sinensis essential oil (AsEO)

Dengue and Zika viruses

SEM, TEM, EDS, XRD FTIR, U-Vis

Spherical

15 to 55 nm

Aedes albopictus

Histological studies

Severe destruction of midgut Aedes albopictus

44.23 to 166 ppm

[111]

Essential oil reduction method using Pogostemon cablin essential oil (PcEO)

Dengue and Zika viruses

SEM, TEM, EDS, XRD FTIR, U-Vis

Spherical

16 to 87 nm,

Aedes albopictus

Histological studies

Damage the digestive system of Aedes albopictus

32.49 to 90.05 ppm,

[111]

Green synthesis using Andrographis paniculata (AP-AgNPs), Phyllanthus niruri (PN-AgNPs), Tinospora cordifolia (TC-AgNPs)

Chikungunya virus

UV–Vis, SEM, XRD, FTIR, DLS, zeta potential,

Spherical

AP-AgNPs-70– 95 nm, PN-AgNPs-70 to 120 nm, TC-AgNPs-50–70 nm

Vero cells

Antiviral assay, Cytotoxicity assay, cytopathic effect, MNTD determination

Antiviral

MNTD-AP-AgNPs- 31.25 µg/ml

PN-AgNPs- 125 µg/ml

TC-AgNPs- 250 µg/ml

[112]

Green synthesis method using Cinnamomum cassia

H7N3 Influenza A Virus

UV–Vis, SEM, FTIR,

Spherical

25 to 55 nm

Vero cells

Cytotoxicity Assay- MTT, cytopathic effect analysis, Infectivity Assay,

Interferes with the protein, Cytotoxic

125 µg/ml

[135]

Green synthesis using Ginseng root extract

Influenza A virus

UV–Vis, XRD, FTIR, HR-TEM

Spherical

50 nm, 20 nm, and 2 nm

MDCK Cells

Antiviral assay- SRB assay (sulforhodamine B (SRB) assay)

Antiviral

0.02 and 0.25 M

[136]

Green synthesis using Lampranthus coccineus & Malephora lutea plant extract

HSV-1, HAV-10 virus & Coxsackie B4 virus

TEM, UV–Vis, FTIR

Spherical

10.12 nm to 27.89 nm

VERO cells

MTT assay, Metabolomics profiling (UPLC-MS) & molecular docking

Binds to viral envelop and inhibits penetration, interact with viral genome

5.13 µg/mL

[137]

Green synthesis using Moringa oleifera seed extract

Dengue virus (DEN-2)

UV–Vis, SEM, XRD, FTIR, EXD,

Spherical

100 nm

C6/36 and Vero cells

MTT, DEN-2 growth inhibition assays, Nanoparticle toxicity, plaque assay

Antiviral activity

10.24ppmto 21.17 ppm

[110]

Green synthesis using tannic acid

Herpes simplex virus 2 (HSV-2)

STEM, DLS, UV–Vis, EDX

Spherical

33 ± 7 nm

Mouse model

Flow Cytometry Phenotypic Analysis, Neutralization Assay, Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR assays)

Act as bitter stimulant, increase immune cells,

5 µg/mL

[138]

Liquid-chemical synthesis technology

Kaposi’s sarcoma-associated herpesvirus (KSHV)

TEM

Spherical

5–200 nm

K-HeLa cells

Cytotoxicity assay, Apoptosis analysis, Reactive Oxygen Species Assay, Virion-cell binding and viral entry assay,

Increase ROS, destroy

 < 0.6 μg/ml

[139]

Modified sonochemical reaction method

Herpes Simplex Virus Type 1

SEM, XPS, TGA

Spherical

4 ± 1 nm

Vero African green monkey kidney epithelial cells

Cell Toxicity Assay (XTT-based colorimetric assay), HSV-1 in vitro Assays, plaque reduction assay,

Cytopathic effect, interact with viral glycoprotein

200- 400 µg/mL

[119]

Monodisperse silica core silver nanoaprticles (chemical method)

Influenza A virus (IFV-A)

TEM, SEM, XPS,

Spherical

7–30 nm

MDCK

Plaque assay, real-time RT-PCR assay, ELISA, NA-Fluor Influenza Neuraminidase Assay, Flow cytometry analyses, hemagglutination assay

Interact with outer membrane of virus

-

[140]

Oxidation–reduction reaction

A/Human/Hubei/3/2005 Influenza Virus (H3N2 IFV)

TEM

Spherical

9.5 nm

MDCK cells

In vitro-MTT, hemagglutinin, flow cytometry, immunofluorescence

Damage the structure of virus, inhibit growth

ID50- 12.5 µg/mL

[118]

Chemical synthesis

H1V1 influenza virus

TEM

Spherical

5–20 nm

MDCK cells

Hemagglutination inhibition test, the embryo inoculation assay, Mosmann based MTT assay, flow cytometry assay

Ag + ion suppression respiration of pathogen, inhibitory action on virus

50 µg/mL

[141]

Turkevich method using aqueous trisodium citrate

HIV-1 pNL4.3-GFP + virus, HSV-1 and HSV-2

EDAX, SEM, FTIR, UV–Vis

Spherical

30–60 nm

293 T cells (Human embryonic kidney), (HeLa cell (human cervical cancer cells), HeLa-CD4-CCR5-LTR-β-gal cells, and Vero E6 cells (African green monkey kidney cells)

Anti-HIV infection assays, Anti-HSV infection assay, cell proliferation (WST-1) assay

Inactivate virus

[142]